Huadong pharmaceutical founded a new drug development center company in Beijing.

The QiChaCha app shows that recently, the East China Pharmaceutical New Drug R&D Center Co., Ltd. was established, with Lv Liang as the legal representative and a registered capital of 50 million yuan. Its business scope includes: research and application of cell technology; development and application of human stem cell technology; medical research and experimental development; research and development of new material technology; pharmaceutical wholesale, etc. The equity penetration displayed on QiChaCha shows that the company is indirectly wholly owned by East China Pharmaceutical.